Bristol Myers Squibb Receives a 'Refuse to File' Letter for an Experimental Cancer Therapy on a DeadlineThe Motley Fool • 05/13/20
The No. 1 Pharma Stock Just Crushed Earnings Views — Is BMY Stock A Buy?Investors Business Daily • 05/08/20
3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKlineInvestorPlace • 05/08/20
Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/07/20
From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right NowThe Motley Fool • 05/07/20
Bristol-Myers Squibb (BMY) Tops Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/07/20